Tolerance_NN
to_TO
lipopolysaccharide_NN
involves_VBZ
mobilization_NN
of_IN
nuclear_JJ
factor_NN
kappa_NN
B_NN
with_IN
predominance_NN
of_IN
p50_NN
homodimers_NNS
._.

Stimulation_NN
of_IN
the_DT
human_JJ
monocytic_JJ
cell_NN
line_NN
Mono_NN
Mac_NN
6_CD
with_IN
lipopolysaccharide_NN
-LRB-_-LRB-
LPS_NN
-RRB-_-RRB-
leads_VBZ
to_TO
rapid_JJ
and_CC
transient_JJ
expression_NN
of_IN
cytokines_NNS
like_IN
tumor_NN
necrosis_NN
factor_NN
-LRB-_-LRB-
TNF_NN
-RRB-_-RRB-
._.

When_WRB
such_JJ
cells_NNS
are_VBP
precultured_VBN
for_IN
2_CD
days_NNS
with_IN
a_DT
low_JJ
dose_NN
of_IN
LPS_NN
-LRB-_-LRB-
20_CD
ng\/ml_NN
-RRB-_-RRB-
followed_VBN
by_IN
stimulation_NN
with_IN
a_DT
high_JJ
dose_NN
of_IN
LPS_NN
-LRB-_-LRB-
1_CD
microgram\/ml_NN
-RRB-_-RRB-
,_,
expression_NN
of_IN
the_DT
TNF_NN
gene_NN
is_VBZ
minimal_JJ
,_,
i.e._FW
the_DT
cells_NNS
are_VBP
tolerant_JJ
._.

In_IN
nuclear_JJ
run-on_JJ
analysis_NN
,_,
such_JJ
tolerant_JJ
cells_NNS
show_VBP
only_RB
a_DT
low_JJ
degree_NN
of_IN
transcription_NN
,_,
indicating_VBG
that_IN
tolerance_NN
operates_VBZ
at_IN
or_CC
upstream_JJ
of_IN
the_DT
transcription_NN
level_NN
._.

The_DT
CD14_NN
LPS_NN
receptor_NN
is_VBZ
,_,
however_RB
,_,
up-regulated_VBN
-LRB-_-LRB-
not_RB
down-regulated_VBN
-RRB-_-RRB-
in_IN
tolerant_JJ
cells_NNS
,_,
and_CC
LPS_NN
can_MD
,_,
in_IN
fact_NN
,_,
still_RB
lead_VB
to_TO
activation_NN
of_IN
tolerant_JJ
cells_NNS
as_IN
evidenced_VBN
by_IN
mobilization_NN
of_IN
the_DT
transcription_NN
factor_NN
nuclear_JJ
factor_NN
kappa_NN
B_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
-RRB-_-RRB-
._.

Resolution_NN
of_IN
the_DT
NF-kappa_NN
B_NN
complex_NN
in_IN
gel_NN
shift_NN
analysis_NN
shows_VBZ
that_IN
the_DT
binding_VBG
protein_NN
,_,
mobilized_VBN
in_IN
naive_JJ
Mono_NN
Mac_NN
6_CD
cells_NNS
,_,
consists_VBZ
mainly_RB
of_IN
p50-p65_NN
heterodimers_NNS
,_,
while_IN
in_IN
tolerant_JJ
cells_NNS
,_,
the_DT
p50_NN
homodimer_NN
is_VBZ
predominant_JJ
._.

This_DT
increase_NN
in_IN
p50_NN
homodimers_NNS
coincides_VBZ
with_IN
an_DT
increase_NN
in_IN
p105_NN
mRNA_NN
,_,
suggestive_JJ
of_IN
a_DT
transcriptional_JJ
up-regulation_NN
of_IN
p50_NN
._.

Reporter_NN
gene_NN
analysis_NN
reveals_VBZ
that_IN
the_DT
NF-kappa_NN
B_NN
complex_NN
mobilized_VBN
in_IN
tolerant_JJ
cells_NNS
is_VBZ
functionally_RB
inactive_JJ
in_IN
that_IN
NF-kappa_NN
B-dependent_JJ
luciferase_NN
constructs_NNS
containing_VBG
the_DT
human_JJ
immunodeficiency_NN
virus_NN
long_JJ
terminal_JJ
repeat_NN
or_CC
the_DT
TNF_NN
5_CD
'_NN
-_:
region_NN
show_VBP
only_RB
minimal_JJ
transactivation_NN
after_IN
LPS_NN
stimulation_NN
._.

Similar_JJ
to_TO
Mono_NN
Mac_NN
6_CD
cells_NNS
,_,
primary_JJ
blood_NN
monocytes_NNS
,_,
when_WRB
precultured_VBN
with_IN
a_DT
low_JJ
dose_NN
of_IN
LPS_NN
,_,
also_RB
become_VBP
tolerant_JJ
and_CC
produce_VBP
little_JJ
TNF_NN
after_IN
LPS_NN
stimulation_NN
._.

The_DT
tolerant_JJ
blood_NN
monocytes_NNS
also_RB
up-regulate_VBP
CD14_NN
,_,
and_CC
they_PRP
mobilize_VBP
NF-kappa_NN
B_NN
with_IN
a_DT
predominance_NN
of_IN
p50_NN
homodimers_NNS
._.

Taken_VBN
together_RB
,_,
these_DT
results_NNS
demonstrate_VBP
that_IN
tolerance_NN
to_TO
LPS_NN
is_VBZ
determined_VBN
by_IN
post-receptor_JJ
mechanisms_NNS
that_WDT
involve_VBP
an_DT
altered_JJ
composition_NN
of_IN
the_DT
NF-kappa_NN
B_NN
complex_NN
._.

